At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
CryoBalloon™ Full Ablation System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study to Evaluate the CryoBalloon™ Full and Swipe Ablation Systems for Ablation of Human Esophageal Epithelium
In Brief
A clinical study evaluating CryoBalloon™ Full Ablation System and CryoBalloon™ Swipe Ablation System for Esophageal Cancer. Completed, enrolled 10 participants across 2 sites.
Detailed Summary
This study will evaluate the C2 CryoBalloon™ Full and Swipe Ablation Systems for the ablation of human esophageal epithelium in patients scheduled to undergo esophagectomy for reasons unrelated to the objective of the study
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionOct 2016
Study CompletionOct 2016
TodayJul 2026
First PostedApr 6, 2016
Enrollment StartApr 1, 2016
Primary CompletionOct 24, 2016
Study CompletionOct 30, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.2 years ago
Interventions
CryoBalloon™ Full Ablation Systemdevice
Tissue Ablation using CryoBalloon™ Full Ablation System
CryoBalloon™ Swipe Ablation Systemdevice
Tissue Ablation using CryoBalloon™ Swipe Ablation System